Investors/analysts call with management
Awaiting price reaction for this filing.
JB Pharma has scheduled a conference call for investors and analysts on Thursday, May 15, 2025 at 2:00 PM IST to discuss its Q4 FY25 results and developments for the quarter ended March 31, 2025. The company's financial results for the quarter will be announced a day earlier, on May 14, 2025. Senior management, including the CFO, will be present to address questions from participants. The call can be joined via multiple dial-in numbers for India, Hong Kong, Singapore, UK, and USA, or through pre-registration on the company's website.
This is a routine pre-earnings disclosure and does not signal any material change. Investors should watch for the Q4 FY25 results announcement on May 14, 2025, which will drive the direction of the stock in the short term.